https://clinicaltrials.gov/ct2/show/NCT03903913?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=03%2F21%2F2019&lupd_d=14
Condition : Cystic Fibrosis
Intervention : Drug: S-1226
Sponsor : SolAeroMed Inc.
Not yet recruiting
Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis
NCT03903913
Thu, 04 Apr 2019 12:00:00 EDT
Last Update Posted: 04/04/19 07:50AM
